Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era.

CONCLUSION: Although TPO-RAs long term efficacy and safety still require further investigations, their use is gradually expanding in clinical practice of children with ITP.
PMID: 32473624 [PubMed - as supplied by publisher]

Source: Endocrine, Metabolic and Immune Disorders Drug Targets - June 1, 2020 Category: Drugs & Pharmacology Tags: Endocr Metab Immune Disord Drug Targets Source Type: research